| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/03/2011 | US20110053977 Small molecule e2f inhibitor |
| 03/03/2011 | US20110053964 4-aminoquinazoline derivatives and methods of use thereof |
| 03/03/2011 | US20110053960 Method for treating pain syndrome and other disorders |
| 03/03/2011 | US20110053946 Aryl-Quinolyl Compounds and Their Use |
| 03/03/2011 | US20110053932 Protein Kinase Inhibitors and Methods for Using Thereof |
| 03/03/2011 | US20110053930 Inhibitors of the bmp signaling pathway |
| 03/03/2011 | US20110053929 Imidazo-, pyrazolopyrazines and imidazotriazines and their use |
| 03/03/2011 | US20110053925 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/03/2011 | US20110053886 Delayed Self-Gelling Alginate Systems and Uses Thereof |
| 03/03/2011 | US20110053883 Agent that modulates physiological condition of pests, involved in insect c-jun amino-terminal kinase activity |
| 03/03/2011 | US20110053882 Methods and compounds for preventing and treating a tumour |
| 03/03/2011 | US20110053881 6-Disubstituted Or Unsaturated Bicyclic Nucleic Acid Analogs |
| 03/03/2011 | US20110053878 Acid-sensitive linkers for drug delivery |
| 03/03/2011 | US20110053871 Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation |
| 03/03/2011 | US20110053863 Methods of using flt3-ligand in the treatment of cancer |
| 03/03/2011 | US20110053862 Compositions comprising survivin sirna and methods of use thereof |
| 03/03/2011 | US20110053861 Compositions comprising nuclear factor-kappa b (nf-kb) sirna and methods of use |
| 03/03/2011 | US20110053857 Yeast cells expressing tar dna-binding protein 43 and uses therefor |
| 03/03/2011 | US20110053850 Doc1 compositions and methods for treating cancer |
| 03/03/2011 | US20110053849 Regulation of litaf modulated cytokine production by a novel p53 short peptide |
| 03/03/2011 | US20110053841 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 03/03/2011 | US20110053828 Use of Urea-Adjuvated Polypeptides for Diagnosis, Prophylaxis and Therapy |
| 03/03/2011 | US20110053804 Gene Signatures for the Prognosis of Cancer |
| 03/03/2011 | US20110053787 Compositions and Methods of Detecting Post-Stop Peptides |
| 03/03/2011 | US20110053783 Bioactive surface for hepatocyte-based applications |
| 03/03/2011 | US20110053777 Resistance to Acetolactate Synthase-Inhibiting Herbicides |
| 03/03/2011 | US20110053272 Methods for cloning and manipulating genomes |
| 03/03/2011 | US20110053270 Patterning Hydrogels |
| 03/03/2011 | US20110053269 Laminar construct for tissue-engineered dermal equivalent |
| 03/03/2011 | US20110053268 Method for diagnosis of abnormal iron metabolism using active hepcidin as indicator |
| 03/03/2011 | US20110053267 METHOD FOR PREPARATION OF PLATELET FROM iPS CELL |
| 03/03/2011 | US20110053266 Methods, kits, and compositions for stem cell self-renewal |
| 03/03/2011 | US20110053265 Cell Culture Performance with Betaine |
| 03/03/2011 | US20110053264 Framework residue substituted humanized col-1 antibodies and their use |
| 03/03/2011 | US20110053263 Multipotent Cancer Stem Cell Lines and Method for Producing the Same |
| 03/03/2011 | US20110053262 Methods of fabricating enhanced tissue-engineered cartilage |
| 03/03/2011 | US20110053261 Methods for determining correlated residues in a protein or other biopolymer using molecular dynamics |
| 03/03/2011 | US20110053260 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 03/03/2011 | US20110053259 Recombinant poxvirus expressing homologous genes inserted into the poxvirus genome |
| 03/03/2011 | US20110053248 Serum-Free Virus Propagation Platform For A Virus Vaccine Candidate |
| 03/03/2011 | US20110053241 Device and method for mechanically deforming cells |
| 03/03/2011 | US20110053240 Dna damaging agents in combination with tyrosine kinase inhibitors |
| 03/03/2011 | US20110053222 PC5 as a Factor IX Propeptide Processing Enzyme |
| 03/03/2011 | US20110053221 Recombinant production of authentic human proteins using human cell expression systems |
| 03/03/2011 | US20110053217 Polynucleotides encoding signal peptide-containing molecules |
| 03/03/2011 | US20110053213 Polypeptides Having Ferulic Acid Esterase Activity and Polynucleotides Encoding Same |
| 03/03/2011 | US20110053201 Method of cell separation |
| 03/03/2011 | US20110053185 Culture based screening assay and methods of use thereof to identify agents which modulate tumor development, invasion and differentiation |
| 03/03/2011 | US20110053183 Method of concentrating human mesenchymal stem cells |
| 03/03/2011 | US20110053166 Stem cell expression cassettes |
| 03/03/2011 | US20110053152 Method for cancer detection, diagnosis and prognosis |
| 03/03/2011 | US20110053137 Methods of modulating cold sensory perception |
| 03/03/2011 | US20110052728 Botanical extract from the aqueous stream of the palm oil milling process for the prevention and inhibition of oxidative stress and haemolysis in human red blood cells |
| 03/03/2011 | US20110052693 Method for producing artificial skin |
| 03/03/2011 | US20110052692 Novel hydrogels and uses thereof |
| 03/03/2011 | US20110052676 Composition For Delaying Cellular Senescence |
| 03/03/2011 | US20110052670 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 03/03/2011 | US20110052667 Compositions and methods for inhibiting angiogenesis and tumorigenesis |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052642 Peripheral zone tumor cells, methods for their preparation and use |
| 03/03/2011 | US20110052637 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as vaccines |
| 03/03/2011 | US20110052634 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
| 03/03/2011 | US20110052632 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 03/03/2011 | US20110052631 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells |
| 03/03/2011 | US20110052627 Recombinant modified vaccinia virus measles vaccine |
| 03/03/2011 | US20110052621 Pcsk9 vaccine |
| 03/03/2011 | US20110052617 Aav scleroprotein, production and use thereof |
| 03/03/2011 | US20110052616 Biological materials and uses thereof |
| 03/03/2011 | US20110052615 Tumour-specific animal proteins |
| 03/03/2011 | US20110052614 Stat3 epitope peptides |
| 03/03/2011 | US20110052608 Novel antibodies against prion protein and uses thereof |
| 03/03/2011 | US20110052603 method of treatment and agents useful for same |
| 03/03/2011 | US20110052600 Il-17ra-il-17rb antagonists and uses thereof |
| 03/03/2011 | US20110052599 Facilitation of Oocyte, Zygote and Pre-Implantation Embryo Maturation |
| 03/03/2011 | US20110052598 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 03/03/2011 | US20110052597 Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof |
| 03/03/2011 | US20110052596 Antibodies to il-17a |
| 03/03/2011 | US20110052595 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 03/03/2011 | US20110052593 Breast cancer associated antigen |
| 03/03/2011 | US20110052592 Compositions and Methods for Use for Antibodies Against Sclerostin |
| 03/03/2011 | US20110052591 Variants of Thyroid Stimulating Hormone Beta |
| 03/03/2011 | US20110052587 Peptide or protein comprising a c'-d loop of the cd28 receptor family |
| 03/03/2011 | US20110052586 Antibodies to an epitope of agr2, assays and hybridomas |
| 03/03/2011 | US20110052585 Compositions and methods for inhibiting interleukin pathways |
| 03/03/2011 | US20110052582 Humanized Anti-CDCP1 Antibodies |
| 03/03/2011 | US20110052579 Ligands of the Natural Killer (NK) Cell Surface Marker CD27 and Therapeutic Uses Thereof, |
| 03/03/2011 | US20110052577 Antibodies |
| 03/03/2011 | US20110052574 Method of inhibition of leukemic stem cells |
| 03/03/2011 | US20110052571 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies |
| 03/03/2011 | US20110052558 Materials and methods for prevention and treatment of rna viral diseases |
| 03/03/2011 | US20110052554 Methods for off-the- shelf tumor immunotherapy using allogeneic t-cell precursors |
| 03/03/2011 | US20110052552 Compositions to effect neuronal growth |
| 03/03/2011 | US20110052551 Cardiac myocyte morphogenic compositions and methods of use therefor |
| 03/03/2011 | US20110052549 Cell culture device to differentiate stem cells in a specific orientation |
| 03/03/2011 | US20110052548 Cell culture media to differentiate embryonic stem cells into neuronal lineages |
| 03/03/2011 | US20110052547 Rapamycin-resistant t cells and therapeutic uses thereof |
| 03/03/2011 | US20110052546 Inhibition of SHIP to Enhance Stem Cell Harvest and Transplantation |
| 03/03/2011 | US20110052545 Regeneration system, its production and use |
| 03/03/2011 | US20110052535 Compositions for treating an inflammatory autoimmune condition |
| 03/03/2011 | US20110052529 Methods and compositions for expanding t regulatory cells |